CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allogeneic Blood and Marrow Transplant -

- Topline Results from ReSPECT Study Expected in 2Q 2026 -

Read more at globenewswire.com